More and more overseas patients are beginning to explore China’s innovative drug resources in search of new treatment opportunities. However, for international patients, the real

From precision medicine to immunotherapy, from novel targeted drugs to cell therapy, China has formed unique strengths in several cancer treatment fields. As a platform

In today’s increasingly complex pharmaceutical distribution system and highly active cross-border trade environment, counterfeit medicines have evolved from a national regulatory issue into a global

As Semaglutide, Tirzepatide, and next-generation multi-target peptides like Retatrutide advance in development and commercialization, China’s peptide API industry is entering a new capacity expansion cycle.

Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target to dual-target therapies, driving peptides from early research into large-scale